查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1776815

臨床前影像市場：全球產業分析、市場規模、佔有率、成長、趨勢與未來預測（2025-2032）

Preclinical Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 198 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球臨床前影像市場的全面分析報告。該報告對關鍵市場動態進行了全面評估，包括市場促進因素、趨勢、機會和挑戰，並提供了有關市場結構的詳細見解。報告包含獨家數據和統計數據，概述了全球臨床前影像市場的預測成長軌跡（2025-2032 年）。

關鍵見解

  • 臨床前影像市場規模（2025年）：45億美元
  • 市場規模預測（以金額為準，2032 年）：62 億美元
  • 全球市場成長率（2025-2032年複合年成長率）：4.6%

臨床前影像市場—分析範圍

臨床前影像技術在藥物研發和生物醫學研究中發揮著至關重要的作用，它能夠以非侵入性的方式可視化小動物模型中的生物過程。這些先進的影像技術能夠深入了解疾病機制、藥物動力學和療效，進而加速新型治療方法的開發。臨床前影像市場提供各種影像系統，包括PET、SPECT、MRI、CT、光學影像和超音波技術，以滿足製藥和生物技術公司、研究機構和學術中心的需求。市場發展的驅動力包括：藥物研發投入的增加、對個人化醫療的日益重視，以及提升影像解析度、敏感度和多重模式能力的技術進步。

市場成長動力：

全球臨床前成像市場受多種關鍵因素驅動，包括製藥和生物技術領域研發支出的不斷成長，這推動了對用於評估候選藥物的高精度、高通量成像解決方案的需求。腫瘤學和神經病學研究的日益關注，極大地促進了先進成像系統在早期疾病檢測和治療監測中的應用。 PET/MRI 和 PET/CT 結合的混合成像系統等技術創新，提供了更深入的解剖和功能洞察，推動了市場擴張。此外，政府支持臨床前研究和產學合作的措施也增強了市場成長前景。

市場限制：

儘管成長前景光明，但臨床前影像市場仍面臨與先進影像設備和維護高成本相關的挑戰，這可能會限制其在小型研究機構和學術機構中的應用。嚴格的監管準則和圍繞動物試驗的倫理考慮給市場參與者帶來了額外的操作複雜性和合規負擔。此外，替代性體外測試方法和競爭性藥物篩檢模型的出現可能會與傳統的臨床前影像測試形成競爭，尤其是在某些應用領域。解決成本和倫理障礙需要創新的經營模式、降低系統成本的技術進步，以及持續倡導體內成像在轉化研究中的價值。

市場機會：

臨床前影像市場在免疫腫瘤學、再生醫學和分子影像研究領域的新興應用推動下，提供了巨大的成長機會。影像探針和顯影劑的進步使得特定分子路徑的精準定位和視覺化成為可能，從而拓展了臨床前影像在藥物研發和生物標記檢驗中的效用。此外，將人工智慧和機器學習融入影像分析可以增強資料解讀能力，提高工作流程效率，並縮短研究週期。戰略聯盟、對混合成像模式的投資以及開發經濟高效、易於使用的成像系統，對於抓住這些機會並在不斷發展的臨床前研究領域中保持市場領先地位至關重要。

本報告回答的關鍵問題

  • 推動全球臨床前影像市場成長的關鍵因素有哪些？
  • 哪些顯像模式和應用推動了臨床前影像的應用？
  • 技術進步如何改變臨床前影像市場的競爭格局？
  • 誰是臨床前影像市場的主要企業，他們採取什麼策略來維持市場相關性？
  • 全球臨床前影像市場的新興趨勢和未來前景是什麼？

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 驅動程式
    • 抑制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長預測
  • COVID-19影響分析
  • 預測因子：相關性和影響力

第3章 加值分析

  • 產品採用分析
  • 監管狀況
  • 價值鏈分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第4章 價格分析（2024年）

  • 主要亮點
  • 影響產品價格的關鍵因素
  • 按產品進行價格分析
  • 區域價格和產品偏好

第5章：全球臨床前影像市場展望

  • 主要亮點
    • 市場規模預測（以數量為基礎）
    • 市場規模及年成長率（以金額為準）
    • 絕對的商機
  • 市場規模分析與預測（以金額為準）
    • 歷史市場規模分析（以金額為準，2019-2024）
    • 市場規模分析與預測（以金額為準，2025-2032）
  • 全球臨床前影像市場（按產品）展望
    • 引言/主要發現
    • 歷史市場規模分析：按產品（價值和數量，2019-2024）
    • 按產品分類的市場規模分析和預測（價值和數量基礎，2025-2032 年）
      • 影像系統
      • 試劑
      • 軟體與服務
    • 市場吸引力分析：按產品
  • 全球臨床前影像市場展望（按模式）
    • 引言/主要發現
    • 按模式分類的歷史市場規模分析（以金額為準，2019-2024 年）
    • 按模式分類的市場規模分析與預測（以金額為準，2025-2032）
      • 光學成像
      • 核分子影像
      • 微型磁振造影
      • 微超音波
      • 微型CT
      • 光聲成像（PAT）
      • 磁粒子成像
      • 其他
    • 按模式進行市場吸引力分析
  • 全球臨床前成像市場應用展望
    • 引言/主要發現
    • 按應用分類的歷史市場規模分析（以金額為準，2019-2024）
    • 按應用分類的市場規模分析和預測（以金額為準，2025-2032）
      • 研究與開發
      • 藥物研發
    • 市場吸引力分析：按應用
  • 全球臨床前影像市場（按最終用戶）展望
    • 引言/主要發現
    • 按最終用戶分類的歷史市場規模分析（以金額為準，2019-2024 年）
    • 最終用戶的市場規模分析與預測（以金額為準，2025-2032）
      • 製藥和生物技術公司
      • 學術研究機構
      • 診斷影像中心
      • 其他
    • 最終用戶的市場吸引力分析

6. 全球臨床前影像市場（按地區）展望

  • 主要亮點
  • 按地區分類的歷史市場規模分析（以金額為準，2019-2024 年）
  • 各地區市場規模分析及預測（以金額為準，2025-2032）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

7. 北美臨床前影像市場展望

8. 歐洲臨床前影像市場展望

9. 東亞臨床前影像市場展望

10. 南亞和大洋洲臨床前影像市場展望

11. 拉丁美洲臨床前影像市場展望

12. 中東和非洲臨床前影像市場展望

第13章競爭格局

  • 市場佔有率分析（2024年）
  • 市場結構
    • 競爭強度圖：按市場
    • 競爭對手儀表板
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Bruker
    • Siemens Healthcare Private Limited
    • Revvity
    • FUJIFILM VisualSonics, Inc.
    • Scintica
    • MILabs BV
    • United Imaging Healthcare Co., Ltd.
    • Mediso Ltd.
    • Aspect Imaging Ltd.
    • Inviscan Imaging Systems
    • TriFoil Imaging
    • Southern Scientific Ltd.
    • Iconeus
    • MR Solutions
    • BioPAL, Inc.
    • Viscover

第14章 附錄

  • 分析方法
  • 分析假設
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP34717

Persistence Market Research has recently released a comprehensive report on the worldwide market for preclinical imaging. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global preclinical imaging market from 2025 to 2032.

Key Insights:

  • Preclinical Imaging Market Size (2025E): USD 4.5 Billion
  • Projected Market Value (2032F): USD 6.2 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.6%

Preclinical Imaging Market - Report Scope:

Preclinical imaging plays a crucial role in drug discovery and biomedical research by enabling non-invasive visualization of biological processes in small animal models. These advanced imaging modalities provide critical insights into disease mechanisms, pharmacokinetics, and treatment efficacy, accelerating the development of new therapies. The preclinical imaging market caters to pharmaceutical and biotechnology companies, research institutes, and academic centers, offering a diverse range of imaging systems, including PET, SPECT, MRI, CT, optical imaging, and ultrasound technologies. Market growth is driven by rising investment in drug development, growing emphasis on personalized medicine, and technological advancements enhancing imaging resolution, sensitivity, and multi-modality capabilities.

Market Growth Drivers:

The global preclinical imaging market is propelled by several key factors, including increasing R&D expenditure in pharmaceutical and biotechnology sectors, fueling demand for precise and high-throughput imaging solutions to evaluate new drug candidates. The growing focus on oncology and neurological research significantly contributes to the adoption of advanced imaging systems for early disease detection and treatment monitoring. Technological innovations, such as hybrid imaging systems combining PET/MRI or PET/CT, offer improved anatomical and functional insights, fostering market expansion. Furthermore, government initiatives supporting preclinical research and collaborations between industry and academia strengthen market growth prospects.

Market Restraints:

Despite promising growth prospects, the preclinical imaging market faces challenges related to high costs associated with sophisticated imaging equipment and maintenance, which can limit adoption among smaller research facilities and academic institutions. Stringent regulatory guidelines and ethical considerations surrounding animal research impose additional operational complexities and compliance burdens on market players. Moreover, the availability of alternative in-vitro testing methods and computational models for drug screening may pose competition to traditional preclinical imaging studies, particularly for certain applications. Addressing cost and ethical barriers requires innovative business models, technological advancements to reduce system costs, and continued advocacy for the value of in-vivo imaging in translational research.

Market Opportunities:

The preclinical imaging market presents significant growth opportunities driven by emerging applications in immuno-oncology, regenerative medicine, and molecular imaging research. Advances in imaging probes and contrast agents enable precise targeting and visualization of specific molecular pathways, expanding the utility of preclinical imaging in drug discovery and biomarker validation. Additionally, the integration of artificial intelligence and machine learning into image analysis enhances data interpretation, improves workflow efficiency, and accelerates research timelines. Strategic collaborations, investments in hybrid imaging modalities, and development of cost-effective and user-friendly imaging systems are crucial to capitalizing on these opportunities and maintaining market leadership in the evolving preclinical research landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the preclinical imaging market globally?
  • Which imaging modalities and applications are driving preclinical imaging adoption across research settings?
  • How are technological advancements reshaping the competitive landscape of the preclinical imaging market?
  • Who are the key players contributing to the preclinical imaging market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global preclinical imaging market?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R&D to develop advanced imaging platforms, including hybrid systems and high-resolution imaging technologies, addressing diverse research requirements in oncology, cardiology, and neurology. Collaborations with academic institutions, pharmaceutical companies, and government research agencies facilitate technology adoption and market expansion. Moreover, emphasis on user-friendly software solutions, enhanced imaging probes, and comprehensive customer support services fosters market growth and strengthens competitive positioning in the rapidly advancing preclinical imaging sector.

Key Companies Profiled:

  • Bruker
  • Siemens Healthcare Private Limited
  • Revvity
  • FUJIFILM VisualSonics, Inc.
  • Scintica
  • MILabs B.V.
  • United Imaging Healthcare Co., Ltd.
  • Mediso Ltd.
  • Aspect Imaging Ltd.
  • Inviscan Imaging Systems
  • TriFoil Imaging
  • Southern Scientific Ltd.
  • Iconeus
  • MR Solutions
  • BioPAL, Inc.
  • Viscover

Preclinical Imaging Market Research Segmentation:

The preclinical imaging market encompasses a diverse range of technologies, applications, and end-user segments, addressing various research needs and disease models.

By Product

  • Imaging Systems
  • Reagents
  • Software and Services

By Modality

  • Optical Imaging
  • Nuclear Molecular Imaging
  • Micro MRI
  • Micro Ultrasound
  • Micro CT
  • Photoacoustic Tomography (PAT)
  • Magnetic Particle Imaging
  • Others

By Application

  • Research & Development
  • Drug Discovery & Development

By End-user

  • Pharmaceutical and Biotech Companies
  • Academic and Research Institutes
  • Imaging Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Preclinical Imaging Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Preclinical Imaging Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Preclinical Imaging Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Imaging Systems
      • 5.3.3.2. Reagents
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Preclinical Imaging Market Outlook: Modality
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2024
    • 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
      • 5.4.3.1. Optical Imaging
      • 5.4.3.2. Nuclear Molecular Imaging
      • 5.4.3.3. Micro MRI
      • 5.4.3.4. Micro Ultrasound
      • 5.4.3.5. Micro CT
      • 5.4.3.6. Photoacoustic Tomography (PAT)
      • 5.4.3.7. Magnetic Particle Imaging
      • 5.4.3.8. Others
    • 5.4.4. Market Attractiveness Analysis: Modality
  • 5.5. Global Preclinical Imaging Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 5.5.3.1. Research & Development
      • 5.5.3.2. Drug Discovery & Development
    • 5.5.4. Market Attractiveness Analysis: Application
  • 5.6. Global Preclinical Imaging Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
    • 5.6.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 5.6.3.1. Pharmaceutical and Biotech Companies
      • 5.6.3.2. Academic and Research Institutes
      • 5.6.3.3. Imaging Centers
      • 5.6.3.4. Others
    • 5.6.4. Market Attractiveness Analysis: End User

6. Global Preclinical Imaging Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Preclinical Imaging Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Modality
    • 7.2.4. By Application
    • 7.2.5. By End User
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Imaging Systems
    • 7.4.2. Reagents
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 7.5.1. Optical Imaging
    • 7.5.2. Nuclear Molecular Imaging
    • 7.5.3. Micro MRI
    • 7.5.4. Micro Ultrasound
    • 7.5.5. Micro CT
    • 7.5.6. Photoacoustic Tomography (PAT)
    • 7.5.7. Magnetic Particle Imaging
    • 7.5.8. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.6.1. Research & Development
    • 7.6.2. Drug Discovery & Development
  • 7.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Pharmaceutical and Biotech Companies
    • 7.7.2. Academic and Research Institutes
    • 7.7.3. Imaging Centers
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Preclinical Imaging Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Modality
    • 8.2.4. By Application
    • 8.2.5. By End User
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Imaging Systems
    • 8.4.2. Reagents
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 8.5.1. Optical Imaging
    • 8.5.2. Nuclear Molecular Imaging
    • 8.5.3. Micro MRI
    • 8.5.4. Micro Ultrasound
    • 8.5.5. Micro CT
    • 8.5.6. Photoacoustic Tomography (PAT)
    • 8.5.7. Magnetic Particle Imaging
    • 8.5.8. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.6.1. Research & Development
    • 8.6.2. Drug Discovery & Development
  • 8.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Pharmaceutical and Biotech Companies
    • 8.7.2. Academic and Research Institutes
    • 8.7.3. Imaging Centers
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Preclinical Imaging Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Modality
    • 9.2.4. By Application
    • 9.2.5. By End User
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Imaging Systems
    • 9.4.2. Reagents
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 9.5.1. Optical Imaging
    • 9.5.2. Nuclear Molecular Imaging
    • 9.5.3. Micro MRI
    • 9.5.4. Micro Ultrasound
    • 9.5.5. Micro CT
    • 9.5.6. Photoacoustic Tomography (PAT)
    • 9.5.7. Magnetic Particle Imaging
    • 9.5.8. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.6.1. Research & Development
    • 9.6.2. Drug Discovery & Development
  • 9.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Pharmaceutical and Biotech Companies
    • 9.7.2. Academic and Research Institutes
    • 9.7.3. Imaging Centers
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Preclinical Imaging Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Modality
    • 10.2.4. By Application
    • 10.2.5. By End User
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Imaging Systems
    • 10.4.2. Reagents
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 10.5.1. Optical Imaging
    • 10.5.2. Nuclear Molecular Imaging
    • 10.5.3. Micro MRI
    • 10.5.4. Micro Ultrasound
    • 10.5.5. Micro CT
    • 10.5.6. Photoacoustic Tomography (PAT)
    • 10.5.7. Magnetic Particle Imaging
    • 10.5.8. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.6.1. Research & Development
    • 10.6.2. Drug Discovery & Development
  • 10.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Pharmaceutical and Biotech Companies
    • 10.7.2. Academic and Research Institutes
    • 10.7.3. Imaging Centers
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Preclinical Imaging Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Modality
    • 11.2.4. By Application
    • 11.2.5. By End User
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Imaging Systems
    • 11.4.2. Reagents
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 11.5.1. Optical Imaging
    • 11.5.2. Nuclear Molecular Imaging
    • 11.5.3. Micro MRI
    • 11.5.4. Micro Ultrasound
    • 11.5.5. Micro CT
    • 11.5.6. Photoacoustic Tomography (PAT)
    • 11.5.7. Magnetic Particle Imaging
    • 11.5.8. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.6.1. Research & Development
    • 11.6.2. Drug Discovery & Development
  • 11.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Pharmaceutical and Biotech Companies
    • 11.7.2. Academic and Research Institutes
    • 11.7.3. Imaging Centers
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Preclinical Imaging Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Modality
    • 12.2.4. By Application
    • 12.2.5. By End User
  • 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Imaging Systems
    • 12.4.2. Reagents
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Bn) Analysis and Forecast, By Modality, 2025-2032
    • 12.5.1. Optical Imaging
    • 12.5.2. Nuclear Molecular Imaging
    • 12.5.3. Micro MRI
    • 12.5.4. Micro Ultrasound
    • 12.5.5. Micro CT
    • 12.5.6. Photoacoustic Tomography (PAT)
    • 12.5.7. Magnetic Particle Imaging
    • 12.5.8. Others
  • 12.6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 12.6.1. Research & Development
    • 12.6.2. Drug Discovery & Development
  • 12.7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Pharmaceutical and Biotech Companies
    • 12.7.2. Academic and Research Institutes
    • 12.7.3. Imaging Centers
    • 12.7.4. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Bruker
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Siemens Healthcare Private Limited
    • 13.3.3. Revvity
    • 13.3.4. FUJIFILM VisualSonics, Inc.
    • 13.3.5. Scintica
    • 13.3.6. MILabs B.V.
    • 13.3.7. United Imaging Healthcare Co., Ltd.
    • 13.3.8. Mediso Ltd.
    • 13.3.9. Aspect Imaging Ltd.
    • 13.3.10. Inviscan Imaging Systems
    • 13.3.11. TriFoil Imaging
    • 13.3.12. Southern Scientific Ltd.
    • 13.3.13. Iconeus
    • 13.3.14. MR Solutions
    • 13.3.15. BioPAL, Inc.
    • 13.3.16. Viscover

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations